SkinBioTherapeutics (LSE:SBTX) Additional Paid-In Capital : £13.77 Mil(As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Additional Paid-In Capital?

SkinBioTherapeutics's quarterly additional paid-in capital increased from Dec. 2022 (£8.76 Mil) to Jun. 2023 (£10.95 Mil) and increased from Jun. 2023 (£10.95 Mil) to Dec. 2023 (£13.77 Mil).

SkinBioTherapeutics's annual additional paid-in capital stayed the same from Jun. 2021 (£8.76 Mil) to Jun. 2022 (£8.76 Mil) but then increased from Jun. 2022 (£8.76 Mil) to Jun. 2023 (£10.95 Mil).

SkinBioTherapeutics Additional Paid-In Capital Historical Data

The historical data trend for SkinBioTherapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Additional Paid-In Capital Chart

SkinBioTherapeutics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

Get a 7-Day Free Trial

4.92

8.76

10.95

SkinBioTherapeutics Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial										8.76	8.76	8.76	10.95	13.77

SkinBioTherapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

SkinBioTherapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

SkinBioTherapeutics (LSE:SBTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF

Website

https://www.skinbiotherapeutics.com

SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.